Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9906525 | 0.99 | THRA (0.41) | THRAHPGDTSHRMAPTKDM4E | |
| SCHEMBL816076 | 0.99 | THRA (0.41) | THRAHPGDTSHRMAPTKDM4E | |
| SCHEMBL9906510 | 0.98 | THRA (0.37) | THRAHPGDTSHRMAPTKDM4E | |
| SCHEMBL9906512 | 0.97 | THRA (0.40) | THRAHPGDTSHRMAPTKDM4E | |
| SCHEMBL9906515 | 0.95 | THRB (0.41) | THRAMAPTKDM4EPOLBMAPK1 | |
| SCHEMBL815879 | 0.94 | KDM4E (0.36) | THRAHPGDTSHRMAPTKDM4E | |
| SCHEMBL9906530 | 0.93 | TSHR (0.36) | THRAHPGDTSHRMAPTKDM4E | |
| SCHEMBL20195751 | 0.93 | THRA (0.37) | THRAHPGDTSHRMAPTKDM4E | |
| SCHEMBL9906533 | 0.93 | TSHR (0.36) | THRAHPGDTSHRMAPTKDM4E | |
| SCHEMBL9906538 | 0.93 | TSHR (0.36) | THRAHPGDTSHRMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8197710-B2 | Polymerizable compound and polymerizable composition | ADEKA CORPORATION (JP) | 2012-06-12 | — | — | US | disclosed |
| US-20100294990-A1 | POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100294990-A1 | POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION | PYM1, SCO2, ZYX | THRA 1207/4885HPGD 3414/4885TSHR 2121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.